These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

544 related articles for article (PubMed ID: 16940865)

  • 21. The use of two-dimension electrophoresis to identify serum biomarkers from patients with dengue haemorrhagic fever.
    Thayan R; Huat TL; See LL; Tan CP; Khairullah NS; Yusof R; Devi S
    Trans R Soc Trop Med Hyg; 2009 Apr; 103(4):413-9. PubMed ID: 19203772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship of preexisting dengue virus (DV) neutralizing antibody levels to viremia and severity of disease in a prospective cohort study of DV infection in Thailand.
    Endy TP; Nisalak A; Chunsuttitwat S; Vaughn DW; Green S; Ennis FA; Rothman AL; Libraty DH
    J Infect Dis; 2004 Mar; 189(6):990-1000. PubMed ID: 14999601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Altered T helper 1 reaction but not increase of virus load in patients with dengue hemorrhagic fever.
    Chen RF; Liu JW; Yeh WT; Wang L; Chang JC; Yu HR; Cheng JT; Yang KD
    FEMS Immunol Med Microbiol; 2005 Apr; 44(1):43-50. PubMed ID: 15780577
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dengue and dengue haemorrhagic fever: implications of host genetics.
    Chaturvedi U; Nagar R; Shrivastava R
    FEMS Immunol Med Microbiol; 2006 Jul; 47(2):155-66. PubMed ID: 16831202
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibody responses are generated to immunodominant ELK/KLE-type motifs on the nonstructural-1 glycoprotein during live dengue virus infections in mice and humans: implications for diagnosis, pathogenesis, and vaccine design.
    Falconar AK
    Clin Vaccine Immunol; 2007 May; 14(5):493-504. PubMed ID: 17329445
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-level expression of recombinant dengue viral NS-1 protein and its potential use as a diagnostic antigen.
    Huang JL; Huang JH; Shyu RH; Teng CW; Lin YL; Kuo MD; Yao CW; Shaio MF
    J Med Virol; 2001 Nov; 65(3):553-60. PubMed ID: 11596093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dengue immune response: low affinity, high febrility.
    Welsh RM; Rothman AL
    Nat Med; 2003 Jul; 9(7):820-2. PubMed ID: 12835692
    [No Abstract]   [Full Text] [Related]  

  • 28. Serological markers during dengue 3 primary and secondary infections.
    Vázquez S; Pérez AB; Ruiz D; Rodríguez R; Pupo M; Calzada N; González L; González D; Castro O; Serrano T; Guzmán MG
    J Clin Virol; 2005 Jun; 33(2):132-7. PubMed ID: 15911428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunity and immunopathology in dengue virus infections.
    Kurane I; Ennis FE
    Semin Immunol; 1992 Apr; 4(2):121-7. PubMed ID: 1617166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated levels of total and dengue virus-specific immunoglobulin E in patients with varying disease severity.
    Koraka P; Murgue B; Deparis X; Setiati TE; Suharti C; van Gorp EC; Hack CE; Osterhaus AD; Groen J
    J Med Virol; 2003 May; 70(1):91-8. PubMed ID: 12629649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alternate hypothesis on the pathogenesis of dengue hemorrhagic fever (DHF)/dengue shock syndrome (DSS) in dengue virus infection.
    Noisakran S; Perng GC
    Exp Biol Med (Maywood); 2008 Apr; 233(4):401-8. PubMed ID: 18367628
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dengue and dengue hemorrhagic fever among adults: clinical outcomes related to viremia, serotypes, and antibody response.
    Guilarde AO; Turchi MD; Siqueira JB; Feres VC; Rocha B; Levi JE; Souza VA; Boas LS; Pannuti CS; Martelli CM
    J Infect Dis; 2008 Mar; 197(6):817-24. PubMed ID: 18269315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibodies determine virulence in dengue.
    Halstead SB
    Ann N Y Acad Sci; 2009 Sep; 1171 Suppl 1():E48-56. PubMed ID: 19751402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparison of the transcriptional profiles of patients with dengue fever and dengue hemorrhagic fever reveals differences in the immune response and clues in immunopathogenesis].
    Houghton-Triviño N; Martín K; Giaya K; Rodríguez JA; Bosch I; Castellanos JE
    Biomedica; 2010; 30(4):587-97. PubMed ID: 21713363
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluating the sensitivity of a commercial dengue NS1 antigen-capture ELISA for early diagnosis of acute dengue virus infection.
    Kumarasamy V; Chua SK; Hassan Z; Wahab AH; Chem YK; Mohamad M; Chua KB
    Singapore Med J; 2007 Jul; 48(7):669-73. PubMed ID: 17609831
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Severe dengue virus infection in travelers: risk factors and laboratory indicators.
    Wichmann O; Gascon J; Schunk M; Puente S; Siikamaki H; Gjørup I; Lopez-Velez R; Clerinx J; Peyerl-Hoffmann G; Sundøy A; Genton B; Kern P; Calleri G; de Górgolas M; Mühlberger N; Jelinek T;
    J Infect Dis; 2007 Apr; 195(8):1089-96. PubMed ID: 17357044
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dengue Virus (DV) enhancing antibody activity in preillness plasma does not predict subsequent disease severity or viremia in secondary DV infection.
    Laoprasopwattana K; Libraty DH; Endy TP; Nisalak A; Chunsuttiwat S; Vaughn DW; Reed G; Ennis FA; Rothman AL; Green S
    J Infect Dis; 2005 Aug; 192(3):510-9. PubMed ID: 15995967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dengue virus infection and immune response in humanized RAG2(-/-)gamma(c)(-/-) (RAG-hu) mice.
    Kuruvilla JG; Troyer RM; Devi S; Akkina R
    Virology; 2007 Dec; 369(1):143-52. PubMed ID: 17707071
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dengue virus infection-enhancing activity of undiluted sera obtained from patients with secondary dengue virus infection.
    Moi ML; Takasaki T; Saijo M; Kurane I
    Trans R Soc Trop Med Hyg; 2013 Jan; 107(1):51-8. PubMed ID: 23296697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dengue virus infection of human endothelial cells leads to chemokine production, complement activation, and apoptosis.
    Avirutnan P; Malasit P; Seliger B; Bhakdi S; Husmann M
    J Immunol; 1998 Dec; 161(11):6338-46. PubMed ID: 9834124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.